Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Athira Reports Results From Phase 2/3 LIFT-AD Clinical Trial Of Fosgonimeton For Mild-to-Moderate Alzheimer's Disease; LIFT-AD Trial Did Not Meet Primary Endpoint Of GST And Key Secondary Endpoints Of Cognition And Function

Author: Benzinga Newsdesk | September 03, 2024 04:02pm

Posted In: ATHA